Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Certolizumab is a prescription biologic medicine that blocks tumor necrosis factor-alpha (TNF-alpha) to reduce harmful inflammation. It treats chronic inflammatory conditions like rheumatoid arthritis, Crohn's disease, psoriatic arthritis, and plaque psoriasis via subcutaneous injection.
Certolizumab is a prescription biologic medicine that blocks tumor necrosis factor-alpha (TNF-alpha) to reduce harmful inflammation. It treats chronic inflammatory conditions like rheumatoid arthritis, Crohn's disease, psoriatic arthritis, and plaque psoriasis via subcutaneous injection.